| Title |
Clinical Severity and mRNA Vaccine Effectiveness for Omicron, Delta, and Alpha SARS-CoV-2 Variants in the United States: A Prospective Observational Study
|
|---|---|
| Published in |
medRxiv, February 2022
|
| DOI | 10.1101/2022.02.06.22270558 |
| Pubmed ID | |
| Authors |
Adam S. Lauring, Mark W. Tenforde, James D. Chappell, Manjusha Gaglani, Adit A. Ginde, Tresa McNeal, Shekhar Ghamande, David J. Douin, H. Keipp Talbot, Jonathan D. Casey, Nicholas M. Mohr, Anne Zepeski, Nathan I. Shapiro, Kevin W. Gibbs, D. Clark Files, David N. Hager, Arber Shehu, Matthew E. Prekker, Heidi L. Erickson, Matthew C. Exline, Michelle N. Gong, Amira Mohamed, Nicholas J. Johnson, Vasisht Srinivasan, Jay S. Steingrub, Ithan D. Peltan, Samuel M. Brown, Emily T. Martin, Arnold S. Monto, Akram Khan, Catherine L. Hough, Laurence W. Busse, Caitlin C. ten Lohuis, Abhijit Duggal, Jennifer G. Wilson, Alexandra June Gordon, Nida Qadir, Steven Y. Chang, Christopher Mallow, Carolina Rivas, Hilary M. Babcock, Jennie H. Kwon, Natasha Halasa, Carlos G. Grijalva, Todd W. Rice, William B. Stubblefield, Adrienne Baughman, Kelsey N. Womack, Jillian P. Rhoads, Christopher J. Lindsell, Kimberly W. Hart, Yuwei Zhu, Katherine Adams, Stephanie J. Schrag, Samantha M. Olson, Miwako Kobayashi, Jennifer R. Verani, Manish M. Patel, Wesley H. Self, For the Influenza and Other Viruses in the Acutely Ill Network |
X Demographics
The data shown below were collected from the profiles of 412 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Japan | 95 | 23% |
| United States | 29 | 7% |
| Netherlands | 6 | 1% |
| Canada | 4 | <1% |
| Israel | 4 | <1% |
| Australia | 3 | <1% |
| Austria | 3 | <1% |
| Comoros | 3 | <1% |
| China | 2 | <1% |
| Other | 20 | 5% |
| Unknown | 243 | 59% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 375 | 91% |
| Scientists | 21 | 5% |
| Practitioners (doctors, other healthcare professionals) | 9 | 2% |
| Science communicators (journalists, bloggers, editors) | 7 | 2% |
Mendeley readers
The data shown below were compiled from readership statistics for 42 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 42 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 5 | 12% |
| Student > Bachelor | 4 | 10% |
| Student > Ph. D. Student | 4 | 10% |
| Student > Doctoral Student | 3 | 7% |
| Student > Postgraduate | 3 | 7% |
| Other | 7 | 17% |
| Unknown | 16 | 38% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 9 | 21% |
| Immunology and Microbiology | 3 | 7% |
| Biochemistry, Genetics and Molecular Biology | 3 | 7% |
| Pharmacology, Toxicology and Pharmaceutical Science | 1 | 2% |
| Mathematics | 1 | 2% |
| Other | 5 | 12% |
| Unknown | 20 | 48% |